Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant

To assess anatomical and functional outcomes after switching from dexamethasone implant (DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a multicentric retrospective observational study was conducted. Seventy-five eyes (73.5%) were switched 1–8 weeks after their la...

詳細記述

書誌詳細

主要な著者:	Stéphanie Baillif, Pascal Staccini, Michel Weber, Marie-Noëlle Delyfer, Yannick Le Mer, Vincent Gualino, Laurence Collot, Pierre-Yves Merite, Catherine Creuzot-Garcher, Laurent Kodjikian, Pascale Massin
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-11-01
シリーズ:	Pharmaceutics
主題:	diabetic macular edema dexamethasone implant fluocinolone acetonide implant intravitreal therapy
オンライン･アクセス:	https://www.mdpi.com/1999-4923/14/11/2391
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!